EUVIMEDEUVIMED entdecken
Crossref

Fibroblast growth-factor 23 and vitamin D are associated with iron deficiency and anemia in children with chronic kidney disease

Vasiliki Karava, John Dotis, Antonia Kondou, Athanasios Christoforidis, Anna Taparkou, Evangelia Farmaki, Marina Economou, Nikoleta Printza

Pediatric Nephrology · 2023

DOI: 10.1007/s00467-023-05903-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Nephrology, 2023. Verfasst von Vasiliki Karava und 7 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Nephrology Unit, 1st Department of Pediatrics, Hippokratio General Hospital, Aristotle University of Thessaloniki, 49 Konstantinoupoleos St…. Hauptthemen laut MEDLINE: Anemia, Renal Insufficiency, Chronic, Iron Deficiencies, Vitamin D Deficiency. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 44 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: This cross-sectional study investigates the association of fibroblast growth-factor 23 (FGF23) and other bone mineral parameters with iron status and anemia in pediatric chronic kidney disease (CKD). METHODS: Serum calcium, phosphorus, 25-hydroxyvitamin D (25(OH)D), intact parathormone, c-terminal FGF23, a-Klotho, iron (Fe), ferritin, unsaturated iron-binding capacity, and hemoglobin (Hb) were measured in 53 patients from 5 to 19 years old with GFR 100 ng/mL, TSAT ≤ 20%) were observed in 32% and 7.5% of patients, respectively. In CKD stages 3-4 (36 patients), lnFGF23 and 25(OH)D were correlated with Fe (rs = - 0.418, p = 0.012 and rs = 0.467, p = 0.005) and TSAT (rs = - 0.357, p = 0.035 and rs = 0.487, p = 0.003) but not to ferritin. In this patient group, lnFGF23 and 25(OH)D were correlated with Hb z-score (rs = - 0.649, p < 0.001 and rs = 0.358, p = 0.035). No correlation was detected between lnKlotho and iron parameters. In CKD stages 3-4, in multivariate backward logistic regression analysis, including bone mineral parameters, CKD stage, patient age, and daily alphacalcidol dose as covariates, lnFGF23 and 25(OH)D were associated with low TSΑΤ (15 patients) (OR 6.348, 95% CI 1.106-36.419, and OR 0.619, 95% CI 0.429-0.894, respectively); lnFGF23 was associated with low Hb (10 patients) (OR 5.747, 95% CI 1.270-26.005); while the association between 25(OH)D and low Hb did not reach statistical significance (OR 0.818, 95% CI 0.637-1.050). CONCLUSIONS: In pediatric CKD stages 3-4, iron deficiency and anemia are associated with increased FGF23, independently of Klotho. Vitamin D deficiency might contribute to iron deficiency in this population. A higher resolution version of the Graphical abstract is available as Supplementary information.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnemiaRenal Insufficiency, ChronicIron DeficienciesVitamin D DeficiencyAnemia, Iron-DeficiencyHumansChildChild, PreschoolAdolescentYoung AdultAdultCross-Sectional StudiesIronVitamin DFerritinsMineralsHemoglobinsFibroblasts

Stichwörter der Autor:innen

Chronic kidney diseaseFGF23HemoglobinKlothoTransferrin saturationVitamin D

Substanzen

IronVitamin DFerritinsMineralsHemoglobins

Autor:innen und Institutionen

  • Pediatric Nephrology Unit, 1st Department of Pediatrics, Hippokratio General Hospital, Aristotle University of Thessaloniki, 49 Konstantinoupoleos Street, 54642, Thessaloniki, Greece. vasilikikarava@hotmail.fr.
  • Pediatric Nephrology Unit, 1st Department of Pediatrics, Hippokratio General Hospital, Aristotle University of Thessaloniki, 49 Konstantinoupoleos Street, 54642, Thessaloniki, Greece.
  • Pediatric Endocrinology Unit, 1st Department of Pediatrics, Hippokratio General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Pediatric Immunology and Rheumatology Referral Center, 1st Department of Pediatrics, Hippokratio General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Pediatric Hematology Unit, 1st Department of Pediatrics, Hippokratio General Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Zitieren

APA

Karava, V., Dotis, J., Kondou, A., Christoforidis, A., Taparkou, A., Farmaki, E., Economou, M., & Printza, N. (2023). Fibroblast growth-factor 23 and vitamin D are associated with iron deficiency and anemia in children with chronic kidney disease. Pediatric Nephrology. https://doi.org/10.1007/s00467-023-05903-3

Vancouver

Karava V, Dotis J, Kondou A, Christoforidis A, Taparkou A, Farmaki E, et al. Fibroblast growth-factor 23 and vitamin D are associated with iron deficiency and anemia in children with chronic kidney disease. Pediatric Nephrology. 2023. doi:10.1007/s00467-023-05903-3

BibTeX
@article{Karava2023,
  author = {Karava, Vasiliki and Dotis, John and Kondou, Antonia and Christoforidis, Athanasios and Taparkou, Anna and Farmaki, Evangelia and Economou, Marina and Printza, Nikoleta},
  title = {Fibroblast growth-factor 23 and vitamin D are associated with iron deficiency and anemia in children with chronic kidney disease},
  journal = {Pediatric Nephrology},
  year = {2023},
  doi = {10.1007/s00467-023-05903-3}
}
Kostenlos starten →